Ceniza, Hiacenth Blight P.
HRN: 21-84-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/08/2022
09/14/2022
IVT
75
Q12
Bacteremia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes